相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stabilizing the Pro-Apoptotic BimBH3 Helix (BimSAHB) Does Not Necessarily Enhance Affinity or Biological Activity
Toru Okamoto et al.
ACS CHEMICAL BIOLOGY (2013)
Peptide Ligands for Pro-survival Protein Bfl-1 from Computationally Guided Library Screening
Sanjib Dutta et al.
ACS CHEMICAL BIOLOGY (2013)
PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis
Ariele Viacava Follis et al.
NATURE CHEMICAL BIOLOGY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Stefan P. Glaser et al.
GENES & DEVELOPMENT (2012)
Evaluation of Diverse α/β-Backbone Patterns for Functional α-Helix Mimicry: Analogues of the Bim BH3 Domain
Melissa D. Boersma et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Extending Foldamer Design beyond α-Helix Mimicry: α/β-Peptide Inhibitors of Vascular Endothelial Growth Factor Signaling
Holly S. Haase et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1
Daniela Senft et al.
PLOS ONE (2012)
Structural Basis of Bcl-xL Recognition by a BH3-Mimetic α/β-Peptide Generated by Sequence-Based Design
Erinna F. Lee et al.
CHEMBIOCHEM (2011)
Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis
Peter E. Czabotar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Derek Yecies et al.
BLOOD (2010)
Development of Potent Glucagon-like Peptide-1 Agonists with High Enzyme Stability via Introduction of Multiple Lactam Bridges
Eunice N. Murage et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Determinants of BH3 Binding Specificity for Mcl-1 versus BcI-xL
Sanjib Dutta et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Multiple N-Methylation of MT-II Backbone Amide Bonds Leads to Melanocortin Receptor Subtype hMC1R Selectivity: Pharmacological and Conformational Studies
Lucas Doedens et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance
Brett D. Welch et al.
JOURNAL OF VIROLOGY (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
Michelle L. Stewart et al.
NATURE CHEMICAL BIOLOGY (2010)
High-Resolution Structural Characterization of a Helical alpha/beta-Peptide Foldamer Bound to the Anti-Apoptotic Protein Bcl-x(L)
Erinna F. Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
Meike Vogler et al.
BLOOD (2009)
Novel Bcl-2 Homology-3 Domain-like Sequences Identified from Screening Randomized Peptide Libraries for Inhibitors of the Pro-survival Bcl-2 Proteins
Erinna F. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands
Erinna F. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers
W. Seth Horne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
beta-Peptidic Peptidomimetics
Dieter Seebach et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains
W. Seth Horne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
Erinna F. Lee et al.
JOURNAL OF CELL BIOLOGY (2008)
Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity
Les P. Miranda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1
Catherine L. Day et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
BCL-2 family antagonists for cancer therapy
Guillaume Lessene et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Interplay among side chain sequence, backbone composition, and residue rigidification in polypeptide folding and assembly
W. Seth Horne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: Application to the Bim BH3 domain
Melissa D. Boersma et al.
PROTEIN SCIENCE (2008)
Sophistication of foldamer form and function in vitro and in vivo
Arjel D. Bautista et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Structural insights into the degradation of Mcl-1 induced by BH3 domains
Peter E. Czabotar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
(α/β+α)-Peptide antagonists of BH3 Domain/Bcl-xL recognition:: Toward general strategies for foldamer-based inhibition of protein-protein interactions
Jack D. Sadowsky et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Crystal structure of ABT-737 complexed with Bcl-x(L): implications for selectivity of antagonists of the Bcl-2 family
E. F. Lee et al.
CELL DEATH AND DIFFERENTIATION (2007)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
Chimeric (α/β plus α)-peptide ligands for the BH3-recognition cleft of Bcl-xL:: Critical role of the molecular scaffold in protein surface recognition
JD Sadowsky et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Likelihood-enhanced fast translation functions
AJ McCoy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Binding properties of artificial a helices derived from a hydrogen-bond surrogate: Application to Bcl-xL
DY Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Likelihood-enhanced fast rotation functions
LC Storoni et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
LD Walensky et al.
SCIENCE (2004)
Helical β-peptide inhibitors of the p53-hDM2 interaction
JA Kritzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
PHENIX:: building new software for automated crystallographic structure determination
PD Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
β-amino acids:: Versatile peptidomimetics
DL Steer et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Pushing the boundaries of molecular replacement with maximum likelihood
RJ Read
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2001)
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies
AM Petros et al.
PROTEIN SCIENCE (2000)
Design and synthesis of conformationally constrained glucagon analogues
D Trivedi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
